602 related articles for article (PubMed ID: 19335370)
21. Guidelines for the control of glycopeptide-resistant enterococci in hospitals.
Cookson BD; Macrae MB; Barrett SP; Brown DF; Chadwick C; French GL; Hateley P; Hosein IK; Wade JJ;
J Hosp Infect; 2006 Jan; 62(1):6-21. PubMed ID: 16310890
[TBL] [Abstract][Full Text] [Related]
22. Methicillin-resistant commensal staphylococci in healthy dogs as a potential zoonotic reservoir for community-acquired antibiotic resistance.
Epstein CR; Yam WC; Peiris JS; Epstein RJ
Infect Genet Evol; 2009 Mar; 9(2):283-5. PubMed ID: 19073283
[TBL] [Abstract][Full Text] [Related]
23. [Emergence of vancomycin-dependent enterococci following glycopeptide therapy: case report and review].
Bert F; Leflon-Guibout V; Le Grand J; Bourdon N; Nicolas-Chanoine MH
Pathol Biol (Paris); 2009 Feb; 57(1):56-60. PubMed ID: 18845404
[TBL] [Abstract][Full Text] [Related]
24. Characterization of macrolide resistance in Gram-positive cocci from Colombian hospitals: a countrywide surveillance.
Reyes J; Hidalgo M; Díaz L; Rincón S; Moreno J; Vanegas N; Castañeda E; Arias CA
Int J Infect Dis; 2007 Jul; 11(4):329-36. PubMed ID: 17320446
[TBL] [Abstract][Full Text] [Related]
25. [Update of antimicrobial resistance in Gram-positive microorganisms].
Cercenado E
Med Clin (Barc); 2010 Dec; 135 Suppl 3():10-5. PubMed ID: 21477699
[TBL] [Abstract][Full Text] [Related]
26. A comparison of the antimicrobial resistance patterns of gram-positive cocci isolated from community-private and university-affiliated hospitals from Puerto Rico.
Vázquez GJ; Robledo IE; Arroyo A; Nadal E; Rodríguez R; Bermudez M; Colón M
P R Health Sci J; 2003 Jun; 22(2):131-6. PubMed ID: 12866136
[TBL] [Abstract][Full Text] [Related]
27. Fosfomycin for the treatment of infections caused by Gram-positive cocci with advanced antimicrobial drug resistance: a review of microbiological, animal and clinical studies.
Falagas ME; Roussos N; Gkegkes ID; Rafailidis PI; Karageorgopoulos DE
Expert Opin Investig Drugs; 2009 Jul; 18(7):921-44. PubMed ID: 19548851
[TBL] [Abstract][Full Text] [Related]
28. Methicillin-resistant Staphylococcus aureus infections.
Bartlett JG
Top HIV Med; 2008 Dec; 16(5):151-5. PubMed ID: 19106430
[TBL] [Abstract][Full Text] [Related]
29. Current challenges in treating MRSA: what are the options?
Ratnaraja NV; Hawkey PM
Expert Rev Anti Infect Ther; 2008 Oct; 6(5):601-18. PubMed ID: 18847401
[TBL] [Abstract][Full Text] [Related]
30. Methicillin-resistant Staphylococcus aureus in orthopaedic surgery.
Patel A; Calfee RP; Plante M; Fischer SA; Arcand N; Born C
J Bone Joint Surg Br; 2008 Nov; 90(11):1401-6. PubMed ID: 18978255
[TBL] [Abstract][Full Text] [Related]
31. Bacterial incidence and antibiotic sensitivity pattern in moderate and severe infections in hospitalised patients.
Ghosh A; Karmakar PS; Pal J; Chakraborty N; Debnath NB; Mukherjee JD
J Indian Med Assoc; 2009 Jan; 107(1):21-2, 24-5. PubMed ID: 19588683
[TBL] [Abstract][Full Text] [Related]
32. Selective digestive tract decontamination--will it prevent infection with multidrug-resistant gram-negative pathogens but still be applicable in institutions where methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci are endemic?
Bonten MJ
Clin Infect Dis; 2006 Sep; 43 Suppl 2():S70-4. PubMed ID: 16894518
[TBL] [Abstract][Full Text] [Related]
33. [Antibiotic resistance--bacteria fight back].
Tambić Andrasević A
Acta Med Croatica; 2004; 58(4):245-50. PubMed ID: 15700679
[TBL] [Abstract][Full Text] [Related]
34. Horizontal gene transfer-emerging multidrug resistance in hospital bacteria.
Dzidic S; Bedeković V
Acta Pharmacol Sin; 2003 Jun; 24(6):519-26. PubMed ID: 12791177
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of multidrug-resistant enterococci in a tertiary care hospital in Mumbai, India.
Deshpande VR; Karmarkar MG; Mehta PR
J Infect Dev Ctries; 2013 Feb; 7(2):155-8. PubMed ID: 23416663
[No Abstract] [Full Text] [Related]
36. Antimicrobial susceptibility of Gram-positive bacteria isolated from US medical centers: results of the Daptomycin Surveillance Program (2007-2008).
Sader HS; Jones RN
Diagn Microbiol Infect Dis; 2009 Oct; 65(2):158-62. PubMed ID: 19748426
[TBL] [Abstract][Full Text] [Related]
37. [Recent trend and research issues related to antimicrobial-resistant bacteria].
Yamane K; Arakawa Y
Masui; 2010 Jan; 59(1):4-16. PubMed ID: 20077765
[TBL] [Abstract][Full Text] [Related]
38. In vitro activities of 28 antimicrobial agents against methicillin-resistant Staphylococcus aureus (MRSA) from a clinical setting in Malaysia.
Neela V; Sasikumar M; Ghaznavi GR; Zamberi S; Mariana S
Southeast Asian J Trop Med Public Health; 2008 Sep; 39(5):885-92. PubMed ID: 19058585
[TBL] [Abstract][Full Text] [Related]
39. Glycopeptide-resistant enterococci: deciphering virulence, resistance and epidemicity.
Willems RJ; Bonten MJ
Curr Opin Infect Dis; 2007 Aug; 20(4):384-90. PubMed ID: 17609597
[TBL] [Abstract][Full Text] [Related]
40. Emergence and spread of antibiotic-resistant Gram-positive bacterial pathogens.
Witte W; Cuny C; Klare I; Nübel U; Strommenger B; Werner G
Int J Med Microbiol; 2008 Jul; 298(5-6):365-77. PubMed ID: 18325835
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
